- The trend backdrop is active with a 16-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Activity pressure is constructive, supporting the smart-money activity read.
REVB
LSE
Week ended 07 Aug 2026
Weekly Investor Report
Revolution Beauty Group plc · Consumer Defensive · Household & Personal Products
Latest close
0.04 GBP
-2.5%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 10.3% above the Trend Line and sits at 48.4% of its 52-week range. The latest completed week returned -2.5%, after a -3.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 42/100. Near-term considerations: volume confirmation is below normal.
Setup score
50
out of 100
Latest Close
0.04 GBP
7 Aug 2026
1W Return
-2.5%
latest completed week
4W Return
-3.4%
short-term follow-through
12W Return
21.2%
quarterly tape
Trend Breadth
46.2%
24 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 36.30% based on similar historical setup states.
- The share remains more than 20% below its 52-week high.
- Latest weekly return ranks in the weaker part of its sector group.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.5%
Latest completed week; four-week move -3.4%.
Indicator stack
70/65
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 36.30%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
42/100
12 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 10.3% above the Trend Line and sits at 48.4% of its 52-week range. The latest completed week returned -2.5%, after a -3.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7512-week average 0.51
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership10/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.75Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -3.4% over four weeks, 21.2% over 12 weeks, and 20.2% over one year. The current trend has remained active for 16 consecutive weeks.
Performance by holding period
Active trend streak16 weeks
Active weeks in one year24
Trend breadth46.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.97Latest activity-pressure read.
Pressure change-27.6%Four-week change in activity pressure.
Leadership13.78Latest relative-leadership reading.
RS change-37.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 28 Feb 2026
Field coverage 58%
Model confidence 51%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength30/100Blend of value, momentum, and quality. Underlying universe rank 71; rank 1 is best.
Value35/100Relative valuation strength. Underlying universe rank 66; rank 1 is best.
Quality37/100Profitability and accounting quality. Underlying universe rank 64; rank 1 is best.
Momentum37/100Medium-term price momentum. Underlying universe rank 64; rank 1 is best.
Growth37/100Revenue and earnings growth. Underlying universe rank 64; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- - Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- - Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 36.9% Gross profit retained from each unit of revenue.
- Operating margin
- -18.4% Operating profit retained from revenue.
- Free-cash-flow margin
- -8.8% Free cash flow generated from revenue.
- Return on invested capital
- - Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -28.4% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -655.9% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 2/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- - Net share repurchases relative to market value.
- Shareholder yield
- - Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -1.2x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment42/100
Weighted news tone is negative across 12 relevant articles.
0 positive · 9 neutral · 3 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-34.9%Distance below the 52-week high.
13-week volatility9.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2612 weeks finished lower.
Best week+25.3%Week of 5 Jun.
Worst week-14.5%Week of 3 Apr.
Latest week-2.5%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains7
Flat weeks1
Modest losses4
Sharp losses8
Recent vol9.3%13-week weekly-return volatility.
Base vol8.6%52-week weekly-return volatility.
Up/down split24/27Count of positive and negative weeks in the 52-week window.
Average skew7.5% / -5.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorGB Consumer Defensive
4-week rank51 / 58
Group average3.2%
Trend breadth44.8%
Trend44.8%active weekly trend signals
MD62.1%positive activity pressure
RS29.3%positive relative leadership
Four-week leaders
IndustryGB Household & Personal Products
4-week rank9 / 9
Group average2.5%
Trend breadth44.4%
Trend44.4%active weekly trend signals
MD88.9%positive activity pressure
RS44.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape51/100
Trend, activity pressure, participation, and risk combine to a 51/100 tape read.
Indicator analysis80/100Latest 12-week confirmation: trend 12/12, activity pressure 10/12, relative leadership 10/12.
Activity pressure 0.75; No reversal markers Next-Week ExpectancyNegative 36.30%Next-week expectancy is negative with a 36.30% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors34/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 50 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment42/100Weighted news tone is negative across 12 relevant articles.
Revelation Biosciences (Nasdaq: REVB) posts Q2 loss and flags cash risk Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.04 GBP | -2.5% | 0.04 GBP | 0.14 GBP | 0.97 | 13.78 | 4.6M | On |
| 31 Jul 2026 | 0.05 GBP | -5.8% | 0.04 GBP | 0.14 GBP | 1.18 | 17.10 | 6.0M | On |
| 24 Jul 2026 | 0.05 GBP | -9.4% | 0.04 GBP | 0.14 GBP | 1.33 | 26.10 | 24.8M | On |
| 17 Jul 2026 | 0.05 GBP | 16.2% | 0.04 GBP | 0.15 GBP | 1.30 | 40.82 | 7.5M | On |
| 10 Jul 2026 | 0.05 GBP | -5.4% | 0.04 GBP | 0.15 GBP | 1.35 | 22.14 | 2.5M | On |
| 3 Jul 2026 | 0.05 GBP | -0.2% | 0.04 GBP | 0.15 GBP | 1.38 | 25.97 | 796.7K | On |
| 26 Jun 2026 | 0.05 GBP | -4.9% | 0.04 GBP | 0.15 GBP | 1.44 | 27.82 | 624.7K | On |
| 19 Jun 2026 | 0.05 GBP | 8.7% | 0.04 GBP | 0.15 GBP | 1.20 | 35.77 | 7.2M | On |
| 12 Jun 2026 | 0.05 GBP | 0.9% | 0.04 GBP | 0.15 GBP | 0.78 | 23.17 | 735.5K | On |
| 5 Jun 2026 | 0.05 GBP | 25.3% | 0.03 GBP | 0.16 GBP | 0.42 | 20.37 | 23.7M | On |
| 29 May 2026 | 0.04 GBP | 0.3% | 0.03 GBP | 0.16 GBP | -0.00 | -6.13 | 3.1M | On |
| 22 May 2026 | 0.04 GBP | 1.4% | 0.03 GBP | 0.16 GBP | -0.20 | -8.93 | 1.5M | On |
| 15 May 2026 | 0.04 GBP | 1.4% | 0.03 GBP | 0.16 GBP | -0.27 | -9.98 | 1.5M | On |
| 8 May 2026 | 0.04 GBP | 3.4% | 0.03 GBP | 0.16 GBP | -0.33 | -12.68 | 1.8M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.